Cargando…

Effects of Adjunct Low-Dose Vitamin D on Relapsing-Remitting Multiple Sclerosis Progression: Preliminary Findings of a Randomized Placebo-Controlled Trial

The aim of this preliminary study was to evaluate the effect of low-dose oral vitamin D in combination with current disease-modifying therapy on the prevention of progression of relapsing-remitting multiple sclerosis (RRMS). A phase II double-blind placebo-controlled randomized clinical trial conduc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shaygannejad, Vahid, Janghorbani, Mohsen, Ashtari, Fereshteh, Dehghan, Hamed
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2012
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3337486/ https://www.ncbi.nlm.nih.gov/pubmed/22567287 http://dx.doi.org/10.1155/2012/452541

Ejemplares similares

Combination therapy with mitoxantrone and plasma exchange in aggressive relapsing remitting multiple sclerosis: A preliminary clinical study
por: Tabrizi, Nasim, et al.
Publicado: (2012)

Patterns of attention deficit in relapsing and progressive phenotypes of multiple sclerosis
por: Tabibian, Farinaz, et al.
Publicado: (2023)

Preliminary Study Related the Incidence of Methylprednisolone Pulse Therapy in Patients Visited Multiple Sclerosis Clinic Located at the Isfahan Kashani Hospital
por: Tolou-Ghamari, Zahra, et al.
Publicado: (2013)

The relation between Vitamin D status with fatigue and depressive symptoms of multiple sclerosis
por: Ashtari, Fereshteh, et al.
Publicado: (2013)

Effects of low dose methotrexate on relapsing-remitting multiple sclerosis in comparison to Interferon β-1α: A randomized controlled trial
por: Ashtari, Fereshteh, et al.
Publicado: (2011)

Preliminary study on patients located at the Kashani/Isfahan Hospital with multiple sclerosis between the years 2011 and 2013
por: Tolou-Ghamari, Zahra, et al.
Publicado: (2015)

Efficacy of high-dose vitamin D3 supplementation in vitamin D deficient pregnant women with multiple sclerosis: Preliminary findings of a randomized-controlled trial
por: Etemadifar, Masoud, et al.
Publicado: (2015)

Safety and efficacy of fingolimod in Iranian patients with relapsing-remitting multiple sclerosis: An open-label study
por: Doosti, Rozita, et al.
Publicado: (2021)

Comparable Efficacy and Safety of Teriflunomide versus Dimethyl Fumarate for the Treatment of Relapsing-Remitting Multiple Sclerosis
por: Nehzat, Nasim, et al.
Publicado: (2021)

Psychological well-being in people with multiple sclerosis in an Iranian population
por: Dehnavi, Sedigheh Rezaei, et al.
Publicado: (2015)

Does early-onset multiple sclerosis differ from adult-onset form in Iranian people
por: Ashtari, Fereshteh, et al.
Publicado: (2010)

Comparison of The Expression of miR-326 between Interferon beta Responders and Non-Responders in Relapsing-Remitting Multiple Sclerosis
por: Fattahi, Mahtab, et al.
Publicado: (2020)

Seizure characteristics in multiple sclerosis patients
por: Shaygannejad, Vahid, et al.
Publicado: (2013)

Alternate dosing of fingolimod in relapsing-remitting multiple sclerosis: A systematic review
por: Ghadiri, Fereshteh, et al.
Publicado: (2023)

Effects of vitamin D on retinal nerve fiber layer in vitamin D deficient patients with optic neuritis: Preliminary findings of a randomized, placebo-controlled trial
por: Salari, Mehri, et al.
Publicado: (2015)

A Comparative Study of 25 (OH) Vitamin D Serum Levels in Patients with Multiple Sclerosis and Control Group in Isfahan, Iran
por: Shaygannejad, Vahid, et al.
Publicado: (2010)

Color blindness among multiple sclerosis patients in Isfahan
por: Shaygannejad, Vahid, et al.
Publicado: (2012)

Epigallocatechin Gallate in Relapsing-Remitting Multiple Sclerosis: A Randomized, Placebo-Controlled Trial
por: Bellmann-Strobl, Judith, et al.
Publicado: (2021)

A mechanistic insight into sources of error of visual working memory in multiple sclerosis
por: Motahharynia, Ali, et al.
Publicado: (2023)

Discontinuation and dose reduction of rituximab in relapsing–remitting multiple sclerosis
por: Boremalm, Malin, et al.
Publicado: (2021)

Polymorphonuclear Cell Functional Impairment in Relapsing Remitting Multiple Sclerosis Patients: Preliminary Data
por: Allizond, Valeria, et al.
Publicado: (2015)

Preliminary testing of a patient decision aid for patients with relapsing-remitting multiple sclerosis
por: Bansback*, Nick, et al.
Publicado: (2021)

Preliminary analysis of month of birth in Iranian/Isfahan patients with multiple sclerosis
por: Tolou-Ghamari, Zahra, et al.
Publicado: (2015)

Natural Variation of Vitamin D and Neurofilament Light Chain in Relapsing-Remitting Multiple Sclerosis
por: Røsjø, Egil, et al.
Publicado: (2020)

Postural Control in Relapsing-Remitting Multiple Sclerosis
por: Cusin, Flavia Salvaterra, et al.
Publicado: (2022)

Development and Validation of Fear of Relapse Scale for Relapsing-Remitting Multiple Sclerosis: Understanding Stressors in Patients
por: Khatibi, Ali, et al.
Publicado: (2020)

High-dose vitamin D(3) supplementation in relapsing-remitting multiple sclerosis: a randomised clinical trial
por: Cassard, Sandra D., et al.
Publicado: (2023)

Safety and Efficacy of Fingolimod in Iranian Patients with Relapsing-remitting Multiple Sclerosis
por: Yavari, Fatemeh, et al.
Publicado: (2021)

Study of Type A and B Behavior Patterns in Patients with Multiple Sclerosis in an Iranian Population
por: Shaygannejad, Vahid, et al.
Publicado: (2013)

Optic coherence tomography findings in relapsing-remitting multiple sclerosis patients of the northwest of Iran
por: Talebi, Mahnaz, et al.
Publicado: (2013)

Oral High-Dose Atorvastatin Treatment in Relapsing-Remitting Multiple Sclerosis
por: Paul, Friedemann, et al.
Publicado: (2008)

Half-dose ocrelizumab in selected patients with relapsing–remitting multiple sclerosis
por: Algahtani, Hussein, et al.
Publicado: (2023)

Immune Reconstitution Therapy or Continuous Immunosuppression for the Management of Active Relapsing–Remitting Multiple Sclerosis Patients? A Narrative Review
por: AlSharoqi, Isa Ahmed, et al.
Publicado: (2020)

What is the Real Fate of Vitamin D in Multiple Sclerosis?
por: Shaygannejad, Vahid, et al.
Publicado: (2013)

COVID-19 infection and hospitalization rate in Iranian multiple sclerosis patients: What we know by May 2021
por: Naghavi, Saba, et al.
Publicado: (2022)

Prolyl oligopeptidase is inhibited in relapsing-remitting multiple sclerosis
por: Tenorio-Laranga, Jofre, et al.
Publicado: (2010)

Varicella Zoster Virus and Relapsing Remitting Multiple Sclerosis
por: Sotelo, Julio, et al.
Publicado: (2011)

Disease-modifying therapies in relapsing–remitting multiple sclerosis
por: González-Andrade, Fabricio, et al.
Publicado: (2010)

Teriflunomide in Patients with Relapsing–Remitting Forms of Multiple Sclerosis
por: Chan, Andrew, et al.
Publicado: (2016)

An Overview of Therapeutic Options in Relapsing-remitting Multiple Sclerosis
por: Saleem, Sidra, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_fn313v2n5h7a2ouqp356j6oev8